ABSTRACT RNA-binding proteins regulate multiple steps of RNA metabolism through both dynamic and combined binding. In addition to its crucial roles in cell adhesion and Wnt-activated transcription in cancer cells, b-catenin regulates RNA alternative splicing and stability possibly by binding to target RNA in cells. An RNA aptamer was selected for specific binding to b-catenin to address RNA recognition by b-catenin more specifically. Here, we characterized the structural properties of the RNA aptamer as a model and identified a b-catenin RNA motif. Similar RNA motif was found in cellular RNA, Cyclooxygenase-2 (COX-2) mRNA 3 0 -untranslated region (3 0 -UTR). More significantly, the C-terminal domain of b-catenin interacted with HuR and the Armadillo repeat domain associated with RNA to form the RNA-b-catenin-HuR complex in vitro and in cells. Furthermore, the tertiary RNA-protein complex was predominantly found in the cytoplasm of colon cancer cells; thus, it might be related to COX-2 protein level and cancer progression. Taken together, the b-catenin RNA aptamer was valuable for deducing the cellular RNA aptamer and identifying novel and oncogenic RNA-protein networks in colon cancer cells.
INTRODUCTION
Posttranscriptional regulation of RNA is mediated by RNA-protein interactions between RNA-binding proteins (RBPs) and regulatory sequences in RNA (1) (2) (3) (4) .
RBPs are also associated with many other proteins as a ribonucleoprotein (RNP) complex through proteinprotein interactions and/or RNA-mediated interactions. Thus, combined binding and dynamic remodeling of RNPs is crucial for regulating various steps in RNA metabolism. There may be many thousands of RBPs in vertebrates, which are usually associated with RNA in a sequence-or structure-dependent manner. The number of RBPs is expected to increase if other types of RNAbinding domains are added to the list (5) .
Hu proteins are a family of RBPs with homology to the Drosophila embryonic lethal abnormal vision (ELAV) protein, which include the HuR (HuA), HuB (Hel-N1), HuC and HuD proteins. HuR is ubiquitously expressed, unlike the other members of the ELAV family (HuB, HuC and HuD), which are exclusively found in neuronal tissue (6) . HuR is mostly located in the nucleus, but certain events trigger its translocation to the cytoplasm (7, 8) where it stabilizes various transcripts following stimulation (9) . These transcripts contain AU-rich elements (AREs), and HuR functions as an adaptor protein for the nuclear export of many ARE-containing mRNAs. Regardless of the mechanism, the role of HuR in colon carcinogenesis is crucial (10) . Among HuR-regulated oncogenic transcripts, cyclooxygenase-2 (COX-2) expression is critical for colon cancer tumorigenesis (11, 12) . Many AREs are present in the COX-2 3 0 -untranslated region (3 0 -UTR); thus, the identification and mapping of RBPs and their recognition sites on RNA are necessary (13) (14) (15) (16) (17) .
b-Catenin is a multifunctional protein involved in cell adhesion and transcription downstream of Wnt signaling (18) (19) (20) . The scaffolding proteins adenomatous polyposis coli (APC) and axin interact with b-catenin at cell adherent junctions, and glycogen synthase kinase-3b phosphorylates and inhibits b-catenin proteolysis. However, mutations are frequently found in the b-catenin gene in colon cancer cells, so its protein level rises and accumulates in the nucleus where it activates the transcription of various oncogenic target genes such as cyclin D1 and c-myc (21) (22) (23) (24) . Many proteins interact with b-catenin via the central Armadillo (Arm) repeat domain and through the N-or C-terminal domains (25) . It was reported recently that b-catenin regulates RNA alternative splicing of estrogen receptor-b and RNA stability of unstable transcripts such as COX-2 mRNA (26) (27) (28) (29) (30) . More significantly, b-catenin directly interacts with these RNAs in vitro. However, the mechanism behind these unexpected findings has not yet been systematically studied.
To examine the nature of the b-catenin-RNA interaction, we utilized here the RNA aptamer as a model RNA to map the b-catenin-binding RNA motif. We then showed that b-catenin interacts with an RNA motif within the COX-2 3 0 -UTR, which might be a cellular RNA aptamer. Furthermore, b-catenin interacted with HuR via the C-terminal domain in addition to its association with COX-2 mRNA thru the Arm repeat domain. More interestingly, formation of the tertiary RNP differed depending on tumor progression in colon cancer cells. These findings reveal a novel function of b-catenin, which might explain the altered RNA stabilization of COX-2 mRNA in colon cancer cells.
MATERIALS AND METHODS

Preparation of recombinant proteins and GST pull-down assay
The Arm 1-12 (Arm) bacterial expression vector and full length (FL) Arm have been described previously (30) . b-Catenin fragments for C-terminal (C-term, amino acids 685-781) was obtained by polymerase chain reaction (PCR) amplification of FL-b-catenin. The primers used in this study are shown in Supplementary  Table S1 . PCR fragments were cloned into the pGEX-5X-1 vector. Glutathione-S-transferase (GST)-fusion proteins were purified using glutathioneSepharose 4B beads (GE Healthcare). Recombinant HuR protein was expressed from pGEX-HuR and treated with thrombin. A GST pull-down assay was performed between GST-tagged FL, Arm, C-term b-catenin and GST and recombinant HuR (1:1 ratio).
Preparation of in vitro transcribed RNA and biotinylation
The pUC19-Aptamer was described previously and was cleaved with BamHI for the in vitro transcription (27) . pZEO/Luc-COX-2 3 0 -UTR was used as a template for PCR amplification of the different fragments of COX-2 mRNA (22) . All 5 0 -primers contained the T7 promoter sequence (T7). To prepare templates for 3 0 -UTR fragments, U-1, U-2, U-3 and U-4, primer sets in Supplementary Table S1 were used. For in vitro transcription of RNA transcripts, template DNA (1 mg) was incubated with T7 RNA polymerase (Ambion) for 3 h at 37 C. Biotinylation composition buffer (0.2 mM each of ATP, GTP, UTP and 0.12 mM CTP and 0.08 mM Bio-11-CTP) was used to generate biotinylated RNA.
RNase footprinting
RNA that was labeled in vitro at the 5 0 -end with [g- 32 P] ATP (Amersham) was denatured and renatured in binding buffer. Various concentrations (0, 5, 25 , 50 and 100 nM) of b-catenin protein were added and incubated at 37 C for 15 min. The RNA-protein complexes were incubated with RNase T1, RNase S1 or with RNase V1 at room temperature for 15 min. The gels were dried and analyzed using a PhosphoImager (FUJIX Bio Image Analyzer System).
Surface plasmon resonance
Surface plasmon resonance (SPR) experiments were carried out using a BIACORE 3000 (GE Healthcare) as recommended by the manufacturer. CM5 sensorchips was used and biotinylated RNA was immobilized on the streptavidin-coated flow cells in HBSEP buffer. For RNA-protein binding analyses, various concentrations (0, 5, 10, 20, 40, 80, 160 , 320 and 640 nM) of b-catenin or HuR protein was injected as an analyte in HBSEP buffer. BIA Evaluation 3.1 program was used for evaluation of K D . To test for RNA-mediated protein interaction, 10 nM of protein A was injected into the flow with biotinylated RNA to create RNA-protein complexes on the flow chip, and the background was reset before adding protein B as an analyte.
Biotin RNA pull-down assay
After incubating the biotinylated RNAs (40 nmol) and the whole-cell extracts in TENT buffer [10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 250 mM NaCl and 0.5% Triton X-100] for 30 min at room temperature, the samples were subjected to streptavidin-magnetic bead adsorption and incubated for an additional 30 min. After the incubation, bound beads were washed thrice with PBS.
Cell culture and cell fractionation
Human embryonic kidney 293T (HEK293T) and human colorectal adenocarcinoma HT-29 cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS). HEK293 cells were cultured in MEM with 10% fetal calf serum. The human colorectal cancer cell line LoVo were cultured in RPMI 1640 with 10% FBS. For cell fractionation, cells were rinsed three times in PBS and harvested by scraping into RSB buffer [10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 2.5 mM MgCl 2 , protease inhibitors and ribonuclease inhibitor] containing digitonin (40 mg/ml). The cells were incubated on ice for 5 min and centrifuged at 2000g for 8 min to obtain the cytosolic supernatant. The remaining pellet was resuspended in RIPA buffer, incubated on ice for 5 min, centrifuged at 14 000g for 8 min, and the supernatant was collected as the nuclear extract.
Reporters and site-directed mutagenesis
The luciferase reporters for the U-4 COX-2 3 0 -UTR fragment were cloned into the XbaI site for the pZEO/Luc vector and the SacII site for the pDHFR vector. Introduction of a point mutation into the b-catenin element (ACTTT to CCCCC) in the full-length 3 0 -UTR and U-4 was performed using the sense primer (139-170 of COX-2 3 0 -UTR). A point mutation was introduced into the b-catenin element (ACTTT to GCGCG) of the pU6-aptamer using the sense primer (33-72 of the b-catenin aptamer). Mutants were generated using the QuickChange TM Site-Directed Mutagenesis kit (Stratagene).
RNP immunoprecipitation and co-immunoprecipitation
The basic RNP immunoprecipitation (RNP-IP) procedure was described previously (30) . Briefly, cells were reversibly cross-linked with 0.5% formaldehyde, and immunoprecipitated and bound RNA was analyzed by reverse transcription-polymerase chain reaction (RT-PCR). For co-immunoprecipitation (co-IP), cell lysates were pre-cleared either with Protein G in RIPA buffer for 2 h at 4 C with agitation. After pre-clearing, anti-b-catenin (#610154, BD Biosciences) or anti-HuR (3A2, Santa Cruz Biotechnology) were incubated overnight at 4 C with agitation. Protein G beads were added and tumbled for 3 h. The beads were then washed three times with RIPA buffer. Bound proteins were separated by 10% SDS-PAGE and blotted with monoclonal antibodies that recognize the specific proteins as indicated.
Luciferase reporter assay and siRNA transfection HEK293 cells were seeded on 12-well plates and transfected in triplicate using Lipofectamine (Invitrogen) containing the luciferase reporter plasmid and the pRL-TK plasmid (as internal control) in the presence of expression clones. After 24 h, luciferase activities were measured using the GloMax Õ 20/20 luminometer (Promega). HEK293 or LoVo cells were transfected with 40 nM b-catenin or HuR siRNA using Lipofectamine 2000 according to the manufacturer's protocol. Control GFP siRNA was used as the control.
RESULTS
Arm repeat domain of b-catenin binds RNA aptamer via specific RNA element
We previously used an RNA aptamer and roughly estimated the binding affinity using the RNA electrophoretic mobility shift assay (R-EMSA) (27) . In this study, we further assessed binding affinity and mapped the RNA-binding domain within the b-catenin protein using SPR analysis ( Figure 1A When we predicted the RNA secondary structure of the RNA aptamer using the Mfold RNA-folding program (31), two structures emerged with similar thermodynamic stabilities (Supplementary Figure S1 ). To biochemically confirm the predicted RNA structure, RNase mapping analysis was performed ( Figure 1B ). RNase S1 sensitivity clearly showed two prominent single-stranded regions at 34-37 (UAUA) and around 50-54 (ACUUU) (lanes 3, 8 and 13 in Figure 1B) . Interestingly, when the MC-fold was used to predict the RNA secondary structure, an additional double-stranded conformation was predicted, which more accurately fit our biochemical data (Figures 1C) (32) . The b-catenin-binding sites were mapped to RNase-protected sequences upon binding to b-catenin. Quantitative analysis of each band showed that nucleotides 34-37 and 50-54 were protected by RNase S1 and nucleotide 43-46 by RNase V1. Prominent binding sites for the b-catenin protein were incorporated into the inferred ternary RNA structure determined by MC-fold [kindly provided by Francois Major (32)], which correlated nicely with the two protruding bulges in the tri-bridged structure (magenta in Figure 1D) .
To more clearly demonstrate the critical role of the single-stranded loop with the ACUUU RNA element, site-directed mutagenesis was performed, and the ACUU U sequence on the U6-aptamer was changed to GCGCG (27, 28) . We expressed wild-type and mutant U6-aptamer in HEK293T cells and performed the RNP-IP. In Figure 1E , the wild-type RNA aptamer, but not the mutant, specifically bound to b-catenin. Since a mutation in ACUUU completely disrupted b-catenin binding to the aptamer, this specific RNA motif must be important to binding.
C-terminal domain of b-catenin interacts with HuR and facilitates formation of the RNA bound protein complex in vitro
We next investigated whether RNA bound b-catenin interacted with other proteins. As the Arm repeat is the RNAbinding domain, we then asked which b-catenin domain is involved in the protein-protein interaction with HuR, as we have previously reported a protein-protein interaction between b-catenin and HuR in cells (30) . GST pull-down analysis with various forms of b-catenin revealed that the C-term domain of the protein directly interacted with HuR ( Figure 2A) .
Since there were two separate domains for RNA and HuR bindings, it was predicted that RNA bound FL b-catenin could also interact with HuR, possibly through the exposed C-term domain. To test this hypothesis, we designed experiments based on SPR analysis by sequentially adding two recombinant proteins in the presence or absence of one of the other proteins. Protein A was added to the RNA-coated chip for complex formation, and the background was reset. Then, various concentrations of protein B were added as the analytes ( Figure 2B ). The binding constants were evaluated for protein B binding to the protein A-RNA complex.
The RNA aptamer was coated to the chip, pre-incubated with HuR or b-catenin as protein A, then b-catenin or HuR protein was added as protein B. Strikingly, when FL b-catenin was pre-added as protein A followed by adding HuR as protein B, HuR binding to the RNA-b-catenin complex increased dramatically by more than 34-fold ( Figure 2C ). In sharp contrast, HuR did not interact with the RNA-Arm complex ( Figure 2C ). This clearly demonstrated that RNA-bound FL b-catenin could facilitate the formation of a tertiary complex with HuR through the C-term domain. As an opposite control, HuR was pre-incubated as protein A, then FL b-catenin or the Arm domain were added as protein B. No significant changes in binding affinity were observed, because HuR could not bind to the RNA aptamer as protein A ( Figure 2C ). Taken together, the results indicated that b-catenin and HuR directly comprise the tertiary RNP complex with RNA in vitro, through two separate b-catenin domains, the Arm for RNA binding and the C-term for HuR binding. the b-catenin and HuR-binding RNA elements in COX-2 3 0 -UTR. Sequence analysis of the 3 0 -UTR revealed many prototypic HuR-binding AU-rich elements (AUUUA, diamond arrowhead in Figure 3A ) as well as putative b-catenin-binding RNA elements (ACUUU, oval arrowhead in Figure 3A ). Many AREs were clustered on the proximal region (shown as a Box), so we generated four different fragments derived from the ARE-rich region (Supplementary Figure 2A) . In Figure 3A , six AREs were found in the proximal region of 3 0 -UTR: Fragments U-1 and U-2 have AUUUA class I/II ARE (shown as a diamond), whereas Fragments U-3 and U-4 have class III ARE (UUUU) only (data not shown). A putative b-catenin-binding sequence ACUUU (shown as a circle) was located in U-2, U-3 and U-4. The predicted locations of these elements were mostly in the loop of the stem-loop structure (Supplementary Figure S2B and C) .
SPR analysis with U-1 to U-4 RNA fragments and the recombinant HuR protein was performed to measure the binding affinities of HuR to these four UTR fragments. In Figure 3B and Supplementary Table S1 Figure 3C ). This might explain a previous finding, where the F1 fragment (as same as U-1) of COX-2 3 0 -UTR was shown to bind b-catenin by the supershift assay (30) . In contrast, binding affinity to negative control (NC) RNA (Supplementary Figure 2A) could not be evaluated by SPR.
A biotin RNA pull-down assay was performed to understand the cellular protein binding patterns on the COX-2 3 0 -UTR ( Figure 3D ). COX-2 3 0 -UTR fragments (U-1 to U-4) were biotin labeled and their bindings to cellular b-catenin and HuR proteins from HT-29 colorectal adenocarcinoma were analyzed by western blotting. The cellular HuR protein associated with U-1, U-2 and U-3 but not with U-4, whereas cellular b-catenin bound most of the RNA fragments with different binding affinities ( Figure 3D ). U-4 was the RNA fragment that was specifically bound by b-catenin but not by HuR. The cellular b-catenin protein also associated with U-1 but not with the coding region (CR) of COX-2 mRNA or the GAPDH mRNA 3 0 -UTR (Supplementary Figure  S2A D ). Taken together, we conclude that U-4 is the b-catenin-specific RNA fragment from the COX-2 3 0 -UTR. in the FL 3 0 -UTR (wt and mut) and in U-4 (U-4wt and U-4mut). Reporters with U-1 and Delta ARE were also utilized ( Figure 4A ).
To test the role of the ACUUU sequence in cellular b-catenin binding, wt or mut FL 3 0 -UTR were transfected into HEK293 cells and the RNP-IP was performed ( Figure 4B ). The wt 3 0 -UTR bound to b-catenin as shown by the P2 primer, which amplified sequences around ACUUU ( Figure 4B ). More convincingly, when b-catenin was overexpressed, b-catenin binding increased only in response to the wt 3 0 -UTR (Supplementary Figure 3A) . As expected, binding of HuR to its binding sites in the proximal and distal AUUUA sequences in the 3 0 -UTR was detected with the P1 and P3 primers, respectively ( Figure 4B and Supplementary Figure S3B) . The PCR primers for the luciferase gene were used as a control for the expression of the reporters.
Since U-4 is a b-catenin-specific minimal fragment, RNA specificity was tested by the RNP-IP with U-4wt and U-4mut reporters and analyzed with the P2 primer ( Figure 4C ). The RNA aptamer was used as a positive control for b-catenin binding in the cells. The specificity of HuR binding on the typical ARE in the proximal and distal region of the 3 0 -UTR was again confirmed with the P1 and P3 primers ( Figure 4D ). We also used the luciferase reporter with the c-myc 3 0 -UTR as a NC RNA for the RNP-IP (Supplementary Figure S3C) , because we have previously reported that b-catenin does not bind c-myc mRNA and is unable to regulate c-myc mRNA stability (28) .
The luciferase assay was performed with the U-4wt and U-4mut reporters to test if b-catenin could affect COX-2 protein expression via U-4 in the 3 0 -UTR ( Figure 4E ). b-Catenin dramatically increased the luciferase activity by up to 10-fold when the ACUUU element was present in U-4. However, a mutation in U-4 made it completely unresponsive to b-catenin overexpression, which strongly suggests that the ACUUU sequence is a specific functional element for b-catenin. Interestingly, HuR also increased wild-type reporter activity but not mutant reporter activity, albeit to a lesser extent.
To directly test the role of b-catenin and HuR on COX-2 protein level, a knock-down analysis was performed in LoVo colon adenocarcinoma cells. b-Catenin siRNA completely inhibited COX-2 protein expression, whereas HuR siRNA did not alter COX-2 protein levels in LoVo cells ( Figure 4F ). Taken together, cooperative binding of b-catenin and HuR on COX-2 mRNA seemed to be crucial for COX-2 protein expression in the cells.
b-Catenin-HuR-RNA complex is located in the colon cancer cell cytoplasm Activation and subcellular re-distribution of b-catenin and HuR were strongly related to cancer progression, and overexpression of the COX-2 protein is one of the characteristics of colon cancer. Therefore, it would be interesting to test whether the tertiary RNP complex formation with COX-2 mRNA is associated with oncogenic localization of these proteins and COX-2 overexpression during tumorigenesis. Here, we used HEK293 cells as a model of normal cells and LoVo as colorectal cancer cells, and found that COX-2 protein and mRNA expression was vastly different between the two cell types ( Figure 5A ). Subcellular fractionation was combined with RNP-IP to test whether b-catenin and HuR RNP formed differently in normal and cancer cells. In Figure 5B , a relatively low level of b-catenin or HuR binding to COX-2 mRNA was detected both in the nucleus and in the cytoplasm of HEK293 cells ( Figure 5B ). In contrast, b-catenin and HuR interacted with COX-2 mRNA exclusively in the cytoplasm of LoVo cells (Figure 5C and D) . These results suggest that cytoplasmic interaction of b-catenin and HuR on RNA might be important for COX-2 mRNA overexpression in cancer cells in Figure 5A . Moreover, the co-IP analysis with fractionated cells was consistent with the above RNP data as well as our previous reports on b-catenin and HuR interaction in colon cancer cells (30) . Protein-protein interactions between b-catenin and HuR occurred exclusively in the cytoplasm of LoVo cells ( Figure 5E ), as was observed in HT-29 colon adenoma carcinoma cells (30) . The distribution of the b-catenin and HuR proteins and proper cellular fractionation was confirmed by western blot analysis (Supplementary Figure S3D) . Taken together, these results suggest that the formation and transport of the tertiary RNP complex was different between normal and cancer cells. They also strongly suggest that cytoplasmic RNP might be important for the elevated level of COX-2 protein in cancer cells.
DISCUSSION
How b-catenin binds to RNA inside of cells and how it modulates multiple steps of posttranscription need to be better understood. This study provided biochemical and cell biological evidences that b-catenin could binds the RNA through the ACUUU motif in cellular RNA. In addition, combinatorial binding with HuR could result in the formation of an RNP complex with COX-2 mRNA through distinct and non-overlapping binding sites in 3 0 -UTR. b-Catenin could also bind to RNA via the Arm domain and HuR could bind to RNA via the C-terminal domain, which facilitated the tertiary RNP complex formation in vitro and in cells. More importantly, this RNP was predominantly found in the cytoplasm of colon cancer cells as shown in the model in Figure 5F . Since b-catenin and HuR localization are greatly changed in cancer cells when compared to normal cells, the identification of b-catenin as a RBP and its binding RNA element could explain the significant impact of oncogenic b-catenin on cancer cell development.
Here, we showed that Arm repeats of the b-catenin protein could be a novel RNA-binding domain with sequence and/or structure-based recognition. As b-catenin might be a novel ARE-binding RBP, the list of potential RBPs may be larger than previously envisioned. Arm repeat domains are common sites for protein binding in cells. Since we have shown here that b-catenin interacts with RNA, RNA-mediated proteinprotein interactions might be one form of such diverse intracellular interactions involving the Arm domains. When considering the many interaction partners of b-catenin, the RNA molecule could provide a platform for the complex formation in cells. The structures of the Arm domain and its binding proteins, such as TCF4, TCF3, E-cadherin and APC, have been extensively studied (33) (34) (35) (36) (37) . Twelve Arm repeats are organized in a right-handed superhelical twist with a shallow, highly positively charged groove that has been proposed to provide a binding pocket for interacting proteins. The positively charged groove of the b-catenin superhelix makes extensive contacts with many negatively charged residues in the extended N-terminus of TCF proteins (38) . The striking structural resemblance of Arm repeats to Pumilio and FBF homology protein (PUF) repeats could provide novel insights on the structure of the Arm-RNA interaction based on the RNA recognition patterns of PUF repeats (39, 40) .
COX-2 gene expression is generally regulated at the posttranscriptional level by multimeric proteins such as ARE-binding proteins (ARE-BPs) (22, 23, 30) . ARE-BPs regulate RNA stability either by recruiting or by excluding exosomes on target transcripts so they are critical regulators of inflammation and cancer (41) . Since most ARE-BPs share similar RNA sequences, it would be important to determine whether they compete or cooperate for the same binding sites. Complicated binding patterns of ARE-BPs on the same transcripts could greatly affect RNA stability depending on RNA-protein as well as protein-protein interactions between them (42). For example, this was observed for AUF1 and HuR, which bound to both distinct, non-overlapping sites, and on common sites in a competitive fashion. In the case of AUF1 and HuR ARE-BPs, they interact with the p16 3 0 -UTR in a cooperative manner and compete for the p21 3 0 -UTR (43, 44) . Interestingly, HuR knockdown reduced COX-2 mRNA level but did not lead to a dramatic reduction in protein level ( Figure 4F ), probably because many distinct RBPs are associated with the COX-2 3 0 -UTR depending on the cell line, and translational regulation is much more complicated (24, (45) (46) (47) . Thus, our data may reflect the complexity of RNA stability and translation of COX-2 protein expression in cancer cells.
Our data suggest that b-catenin and HuR collaboratively associate with COX-2 3 0 -UTR by binding to distinct RNA elements to form a tertiary RNP complex. However, it is still possible that they could compete for other transcripts depending on the locations of their targets as well as on the overall structure of RNA. Therefore, more extensive studies on the RNA-mediated interaction between b-catenin and HuR on various target transcripts are needed. Interestingly, several reports have suggested that there are inter-relationships between b-catenin and HuR at the posttranscriptional level (48) . Therefore, oncogenic roles of b-catenin and HuR in cancer cells might be related to cooperative or competitive binding of the two proteins depending on mRNA during the course of tumor progression.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online: Supplementary Tables 1 and 2 and Supplementary  Figures 1-3 .
